The past three years have generated millions of case vignettes of patients with COVID-19 respiratory illness. The most dramatic cases include critically ill inpatients with severe hypoxemia despite maximum respiratory support.
By far, the most notable cases of survival have occurred with the administration of ivermectin. Former NIH researcher David Scheim, PhD, early in the pandemic proposed that SARS-CoV-2 Spike protein was acting like a grappling hook pulling together circulating red blood cells into long chains and clumps in a process called hemagglutination. This explained why the red blood cells could not carry oxygen normally and was congruent with the finding of micro blood clots in the lungs. Recently, Boschi et al have provided additional support for this mechanism.[i] In a spectacular publication, Stone et al, describes the prompt improvement of oxygenation in patients with ivermectin.[ii]…